Abstract 2405: A first-in-class IKZF1/3 degrader antibody conjugate (DAC) as a potential myeloma treatment.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Shuai Wu, Jinyu Yang, Mo Dan, Xiwu Hui, Bing Yao, Miaomiao Wei, Bin Bao, Qiwen Zhu, Linlin Xiao, Penghui Wen, Xiaodan Zhang, Wei Fang, Xiao Li
Institution: CSPC Pharmaceutical Group
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148823671
Cites:
Cited by:
Related to: